News Center

Rotterdam, June 23, 2025 – Delft-based construction tech company Resilient Infra B.V. has launched commercial production of BioConcrete 3.0, a bacteria-enhanced self-healing concrete scientifically proven to extend infrastructure service life by 30–50 years.

Core Innovation:

•Embedded Bacillus cohnii spores activate upon water infiltration into micro-cracks (≤0.8mm width)

•Microbial metabolic process precipitates calcite (CaCO₃) to seal damage within 72 hours

•Eliminates 80% of traditional repair needs

Validation Data:

•Rotterdam Port Tunnel (24-month trial): Maintenance costs reduced by €4.3M/year

•EU Infrastructure Lab certification: Withstands 200+ freeze-thaw cycles without structural decay

•Carbon footprint: 37% lower than conventional concrete (ISO 14064-verified)

Market Impact:

•First deployment in EU’s TEN-T core network (2026–2030)

•Global licensing agreements signed with LafargeHolcim (Europe) and UltraTech (Asia)

•Projected to capture 12% of the $700B global concrete market by 2028

Source: Resilient Infra technical whitepaper (June 2025), validated by TÜV Rheinland and the European Construction Technology Platform.